Rapid Therapeutic Science Laboratories, Inc. Convertible Debt, Noncurrent
Rapid Therapeutic Science Laboratories, Inc. had Convertible Debt, Noncurrent of $3.45 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:ConvertibleDebtNoncurrent · last filed 2023-08-14
- 2023-06-30: Convertible Debt, Noncurrent $3.45M.
- 2023-03-31: Convertible Debt, Noncurrent $3.42M.
- 2022-12-31: Convertible Debt, Noncurrent $3.45M.
- 2022-09-30: Convertible Debt, Noncurrent $3.39M.
| Period end | Convertible Debt, Noncurrent | Convertible Debt, Noncurrent as first filed |
|---|---|---|
| 2023-06-30 | $3.45M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $3.42M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $3.45M 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $3.39M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $3.09M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.78M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $1.53M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $888.46K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $150.00K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $150.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.01M 10-K · filed 2022-03-16 | $315.24K 10-KT · filed 2021-03-16 |
| 2020-09-30 | $315.24K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $315.24K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $315.24K 10-KT · filed 2021-03-16 | |
| 2019-12-31 | $465.24K 10-Q · filed 2020-03-31 | |
| 2019-09-30 | $2.20M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $2.20M 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $2.20M 10-K · filed 2020-06-29 | |
| 2018-12-31 | $2.20M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $2.20M 10-Q · filed 2019-01-15 | |
| 2018-06-30 | $2.20M 10-Q · filed 2019-01-15 | |
| 2018-03-31 | $2.20M 10-K · filed 2019-07-09 | |
| 2017-03-31 | $0.00 10-K · filed 2018-12-06 |